The WHO Collaborating Centre for Viral Hepatitis at The Doherty Institute has been designated as one of only five Collaborating Centres for Viral Hepatitis globally. The Centre performs a broad range of activities supporting global control of viral hepatitis, including basic research and reference virology, surveillance, treatment and prevention initiatives, and training and capacity building.
Staff within the Centre actively contribute to improving knowledge and understanding of viral hepatitis in both the scientific and public health domains through a number of forums. Centre staff publish in a wide range of scientific journals, produce reports for public health organisations and other stakeholders, and also participate in a wide range of WHO and other international meetings and workshops.
A key aspect of Australia’s National Hepatitis B Strategy is the identification of specific measurable aims and targets, including increasing the proportion of people living with chronic hepatitis B (CHB) who have been diagnosed, increasing treatment uptake in those affected, and reducing the burden of attributable morbidity and mortality associated with the disease. We work to track progress towards these targets, including future projections and variations by jurisdiction.
The WHO Collaborating Centre for Viral Hepatitis is a research centre located within VIDRL at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
For any enquires, please contact:
T: +61 (0) 3 9342 9377
F: +61 (0) 3 9342 9380
E: whoccvh@mh.org.au
Public Health
